cycloheximide has been researched along with Tauopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Cole, PA; Gan, L; Haroutunian, V; Huang, EJ; Masliah, E; Meyers, D; Min, SW; Mukherjee, C; Ott, M; Schroeder, S; Seeley, WW; Shen, Y; Zhou, Y | 1 |
1 other study(ies) available for cycloheximide and Tauopathies
Article | Year |
---|---|
Acetylation of tau inhibits its degradation and contributes to tauopathy.
Topics: Acetylation; Analysis of Variance; Animals; Animals, Newborn; Carbazoles; Cells, Cultured; Cerebral Cortex; Cycloheximide; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Humans; Immunoprecipitation; Mice; Mice, Transgenic; Models, Biological; Mutation; Neurons; p300-CBP Transcription Factors; Phosphorylation; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sirtuin 1; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; tau Proteins; Tauopathies; Time Factors; Transfection; Ubiquitination | 2010 |